June 7, 2015
Xolair treats CSU patients better than placebo
Novartis reports new analysis showing Xolair® improving quality of life by 78% for chronic spontaneous urticaria patients New analysis from…
Pharmaceuticals, Biotechnology and Life Sciences
Novartis reports new analysis showing Xolair® improving quality of life by 78% for chronic spontaneous urticaria patients New analysis from…